COVID-19 Testing: Impact of Omicron variants on diagnostic reliability
Article Sidebar
Downloads
Submit your own article
Register as an author to reserve your spot in the next issue of the Medical Research Archives.
Author RegistrationJoin the Society
The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.
Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.
MembershipMain Article Content
Abstract
Rapid antigen testing continues to be recommended across the world for the prevention of transmission of SARS-CoV-2 for anyone with COVID-19 symptoms, recent exposure, those visiting high-risk individuals or those recently in crowded spaces while traveling without wearing a mask. Evidence of decreasing diagnostic reliability of individual tests and potential benefits and harms of non-targeted testing is increasingly becoming a concern across the world. Recent research has found multiple commonly used rapid antigen tests have diagnostic sensitivities below 30%, with sensitivities at or near 0% the first 48 hours of infection, when using polymerase chain reaction (PCR) test positivity as the gold standard. Common rapid antigen test sensitivities are lower in individuals previously infected with COVID-19 or in the setting of the BA.4 and BA.5 omicron subvariants. The changes in the rapid antigen test diagnostic sensitivities is a concern with the rapidly changing Omicron variants entering the population as an effective screening tool. With the decreasing diagnostic reliability, potential detrimental effects and lack of evidence to support continued community-based testing, what is the most up to date advice for institutions and providers regarding testing? In this review, we are critically appraising the current utility of community-based rapid antigen testing for COVID-19.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html
2. Centers for Disease Control and Prevention. COVID-19. CDC website. Updated August 22, 2023. Accessed February 21, 2024.
https://wwwnc.cdc.gov/travel/diseases/covid19
3. National Institutes of Health (NIH). NIH website. COVID-19 Testing. Accessed February 21, 2024. https://covid19.nih.gov/covid-19-topics/covid-19-testing
4. Helse Norge. Coronavirus. Helse Norge website. Accessed February 20, 2024. https://www.helsenorge.no/en/coronavirus/
5. Danish Health Authority. Only close contacts exposed to infection at home should self-isolate. DHA website. Published December 2021. Accessed February 21, 2024.
https://sst.dk/en/english/News/2021/Only-close-contacts-exposed-to-infection-at-home-should-self-isolate
6. Kilgore JR, Johnston JR, Van Der Pol B, et al. Use of a Screening Protocol to Identify Asymptomatic COVID-19 in a Free Community Health Clinic in Shelby County, Alabama, October 2020-February 2021. Public Health Rep. 2022;137(5):826-831. doi:10.1177/00333549221110289
7. Erikstrup C, Laksafoss AD, Gladov J, et al. Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study. Lancet Reg Health Eur. 2022;21:100497.
doi: 10.1016/j.lanepe.2022.100479
8. Vilches TN, Rafferty E, Wells CR, Galvani AP, Moghadas SM. Economic evaluation of COVID-19 rapid antigen screening programs in the workplace. BMC Med. 2022, 20:452. doi: 10.1186/s12916-022-02641-5
9. Leng T, Hill EM, Thompson RN, Tildesley MJ, Keeling MJ, Dyson L. Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: a modeling study. PLoS Comput Biol. 2022;18 (5):e1010158. doi: 10.1371/journal.pcbi.1010158
10. Høeg TB, Prasad V. Rapid antigen testing for COVID-19: Decreasing diagnostic reliability, potential detrimental effects and a lack of evidence to support continued public funding of community-based testing. Public Health Pract (Oxf). 2023 Nov 23;6:100451. doi: 10.1016/j.puhip.2023.100451
11. Cavazza M, Sartirana M, Wang Y, Falk M. Assessment of a SARS-CoV-2 population-wide rapid antigen testing in Italy: a modeling and economic analysis study. Eur J Publ Health. 2023; 33(5):937-943. doi:10.1093/eurpub/ckad125
12. Dinnes J, Sharma P, Berhane S, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2021;3(3):CD013705.
doi:10.1002/14651858.CD013705.pub2
13. Adamson B, Sikka R, Wyllie AL, Premsrirut P. Discordant SARS-CoV-2 PCR and rapid antigen test results when infectious: a December 2021 occupational case series. medRxiv. 2022. doi: 10.1101/2022.01.04.22268770
14. Venekamp RP, Schuit E, Hooft L, et al. Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional study. CLIN Microbiol Infect. 2023;29(3):391.e1-391.e7. doi: 10.1016/j.cmi.2022.11.004
15. Krenn F, Dächert C, Badell I, et al. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5. Med Microbiol Immunol. 2023;212(5):323-337. doi:10.1007/s00430-023-00775-8
16. Meumann EM, Robson JMB. Testing for COVID-19: a 2023 update. Aust Prescr. 2023; 46(1):13-17. doi: 10.18773/austprescr.2023.007
17. Centers for Disease Control and Prevention. Special Considerations in People Who Are Immunocompromised. Updated February 29, 2024. CDC Website. Accessed March 6, 2024. https://www.covid19treatmentguidelines.nih.gov/special-populations/immunocompromised/
18. Panda PK, Gupta J, Chowdhury SR, et al. Psychological and Behavioral Impact of Lockdown and Quarantine Measures for COVID-19 Pandemic on Children, Adolescents and Caregivers: A Systematic Review and Meta-Analysis. J Trop Pediatr. 2021 Jan 29;67 (1):fmaa122. doi: 10.1093/tropej/fmaa122
19. Ioannidis JPA, Prasad V. Evaluating health system processes with randomized controlled trials. JAMA Intern Med. 2013;173(14): 1279-80. doi:10.1001/jamainternmed.2013.104420.
20. Soni A, Herbert C, Lin H, et al. Performance of Rapid Antigen Tests to Detect Symptomatic and Asymptomatic SARS-CoV-2 Infection: A Prospective Cohort Study. Ann Intern Med. 2023;176(7):975-982. doi: 10.7326/M23-0385